BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12351421)

  • 1. Developmental dissociation of T cells from B, NK, and myeloid cells revealed by MHC class II-specific chimeric immune receptors bearing TCR-zeta or FcR-gamma chain signaling domains.
    Lin WY; Roberts MR
    Blood; 2002 Oct; 100(8):3045-8. PubMed ID: 12351421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains.
    Roberts MR; Cooke KS; Tran AC; Smith KA; Lin WY; Wang M; Dull TJ; Farson D; Zsebo KM; Finer MH
    J Immunol; 1998 Jul; 161(1):375-84. PubMed ID: 9647246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes.
    Tran AC; Zhang D; Byrn R; Roberts MR
    J Immunol; 1995 Jul; 155(2):1000-9. PubMed ID: 7608531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental arrest of NK1.1+ T cell antigen receptor (TCR)-alpha/beta+ T cells and expansion of NK1.1+ TCR-gamma/delta+ T cell development in CD3 zeta-deficient mice.
    Arase H; Ono S; Arase N; Park SY; Wakizaka K; Watanabe H; Ohno H; Saito T
    J Exp Med; 1995 Sep; 182(3):891-5. PubMed ID: 7650493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of peripheral and intestinal T lymphocytes lacking CD3 zeta.
    Simpson S; Holländer G; She J; Levelt C; Huang M; Terhorst C
    Int Immunol; 1995 Feb; 7(2):287-93. PubMed ID: 7734423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TCR zeta-chain immunoreceptor tyrosine-based activation motifs are sufficient for the activation and differentiation of primary T lymphocytes.
    Geiger TL; Leitenberg D; Flavell RA
    J Immunol; 1999 May; 162(10):5931-9. PubMed ID: 10229830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution.
    Alajez NM; Schmielau J; Alter MD; Cascio M; Finn OJ
    Blood; 2005 Jun; 105(12):4583-9. PubMed ID: 15746083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice.
    Markowitz JS; Auchincloss H; Grusby MJ; Glimcher LH
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2779-83. PubMed ID: 8464889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and function of T cells in T cell antigen receptor/CD3 zeta knockout mice reconstituted with Fc epsilon RI gamma.
    Liu CP; Lin WJ; Huang M; Kappler JW; Marrack P
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):616-21. PubMed ID: 9012833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed maturation of CD4- CD8- Fc gamma RII/III+ T and natural killer cell precursors in Fc epsilon RI gamma transgenic mice.
    Flamand V; Shores EW; Tran T; Huang K; Lee E; Grinberg A; Kinet JP; Love PE
    J Exp Med; 1996 Nov; 184(5):1725-35. PubMed ID: 8920861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic T cell-independent tumor immunity after transplantation of universal receptor-modified bone marrow into SCID mice.
    Hege KM; Cooke KS; Finer MH; Zsebo KM; Roberts MR
    J Exp Med; 1996 Dec; 184(6):2261-9. PubMed ID: 8976181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.
    Ni Z; Knorr DA; Bendzick L; Allred J; Kaufman DS
    Stem Cells; 2014 Apr; 32(4):1021-31. PubMed ID: 24307574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling function of reconstituted CD16: zeta: gamma receptor complex isoforms.
    Vivier E; Rochet N; Ackerly M; Petrini J; Levine H; Daley J; Anderson P
    Int Immunol; 1992 Nov; 4(11):1313-23. PubMed ID: 1472481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell tolerance by dendritic cells and macrophages as a mechanism for the major histocompatibility complex-linked resistance to autoimmune diabetes.
    Thiessen S; Serra P; Amrani A; Verdaguer J; Santamaria P
    Diabetes; 2002 Feb; 51(2):325-38. PubMed ID: 11812739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How the immune system learns about self.
    von Boehmer H; Kisielow P
    Sci Am; 1991 Oct; 265(4):74-81. PubMed ID: 1836069
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of antigen on mature lymphocytes is required to induce T cell tolerance by gene therapy.
    Tian C; Bagley J; Iacomini J
    J Immunol; 2002 Oct; 169(7):3771-6. PubMed ID: 12244171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma delta TCR-bearing intraepithelial lymphocytes regulate class II major histocompatibility complex molecule expression on the mouse small intestinal epithelium.
    Matsumoto S; Setoyama H; Imaoka A; Okada Y; Amasaki H; Suzuki K; Umesaki Y
    Epithelial Cell Biol; 1995; 4(4):163-70. PubMed ID: 9439904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential requirement of MHC class II molecules expressed on hematopoietic cells for positive selection of CD4+ thymocytes in TCR alpha beta and TCR beta transgenic mice.
    Fukui Y; Yamamoto K; Koga T; Yamane K; Sasazuki T
    Int Immunol; 1997 Sep; 9(9):1385-91. PubMed ID: 9310842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II beta-chain and alphaIIbbeta3 integrin are expressed on T-cell progenitors in embryonic bone marrow.
    Ody C; Corbel C; Dunon D; Vainio O; A Imhof B
    Mol Immunol; 2001 Jan; 38(1):45-53. PubMed ID: 11483209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.